GlassScriptPhysician profile
Tony D Vu
NPI 1942221346
$6,841.34
in general payments reported to CMS, 2019-2025
21 companies · $580 in 2025
The $580 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $67.82 · 2021: $166 · 2022: $364 · 2023: $318 · 2024: $4,950 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,664 · Honoraria: $150 · Entertainment: $33.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,664.22 |
| Honoraria | $150.00 |
| Entertainment | $33.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $4,613.51 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $507.10 | 2019-2025 | Acuvue |
| Coopervision INC. | $292.58 | 2020-2025 | Misight Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $226.59 | 2023-2024 | Vyzulta |
| Notal Vision, INC. | $183.18 | 2022 | |
| Shire North American Group INC | $170.31 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $155.73 | 2025 | Xdemvy |
| Allergan, INC. | $131.44 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Astellas Pharma US INC | $64.18 | 2024 | Izervay |
| Alcon Vision LLC | $60.76 | 2023-2025 | Eysuvis, Dailies Total1, Total30 |
| Sun Pharmaceutical Industries INC. | $49.71 | 2024-2025 | |
| Visionix USA, INC | $41.67 | 2022 | |
| Optovue, INC. | $39.49 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $33.32 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $30.28 | 2022 | |
| Abb Con-Cise Optical Group LLC | $22.10 | 2019 | |
| Abbvie INC. | $19.95 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $19.87 | 2023 | Tecnis Iol |
| Sight Sciences, INC. | $15.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tony Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.